0000897069-20-000054.txt : 20200127 0000897069-20-000054.hdr.sgml : 20200127 20200127144558 ACCESSION NUMBER: 0000897069-20-000054 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200127 DATE AS OF CHANGE: 20200127 EFFECTIVENESS DATE: 20200127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cambrian BioPharma Inc CENTRAL INDEX KEY: 0001797409 IRS NUMBER: 842985609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359008 FILM NUMBER: 20549026 BUSINESS ADDRESS: STREET 1: 19 MORRIS AVENUE STREET 2: BROOKLYN NAVY YARD, BUILDING 128 CITY: BROOKLYN STATE: NY ZIP: 11205 BUSINESS PHONE: (516) 962-3186 MAIL ADDRESS: STREET 1: 19 MORRIS AVENUE STREET 2: BROOKLYN NAVY YARD, BUILDING 128 CITY: BROOKLYN STATE: NY ZIP: 11205 FORMER COMPANY: FORMER CONFORMED NAME: Cambrian BioPharma Inc. DATE OF NAME CHANGE: 20191219 D 1 primary_doc.xml X0708 D LIVE 0001797409 Cambrian BioPharma Inc 19 MORRIS AVENUE BROOKLYN NAVY YARD, BUILDING 128 BROOKLYN NY NEW YORK 11205 (516) 962-3186 DELAWARE Cambrian BioPharma Inc. Corporation true 2019 James G. Peyer 19 Morris Avenue Brooklyn Navy Yard, Building 128 Brooklyn NY NEW YORK 11205 Executive Officer Director Promoter Christian Angermeyer 19 Morris Avenue Brooklyn Navy Yard, Building 128 Brooklyn NY NEW YORK 11205 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-29 false true true true false 0 4750000 4750000 0 false 5 0 0 0 false Cambrian BioPharma Inc James G. Peyer James G. Peyer Chief Executive Officer 2020-01-17